Skip to main content

MEDIFAST INC Value Stock - Dividend - Research Selection

Medifast inc

ISIN: US58470H1014 , WKN: 889384

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is based in Baltimore, Maryland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Medifast Inc (MED) Q1 2024 Earnings: Revenue Declines Amid Market Challenges

2024-04-29
Company's Performance Aligns Closely with Analyst Projections Despite Revenue Dip

Medifast's (NYSE:MED) Q1 Earnings Results: Revenue In Line With Expectations But Stock Drops 14.3%

2024-04-29
Wellness company Medifast (NYSE:MED) reported results in line with analysts' expectations in Q1 CY2024, with revenue down 49.9% year on year to $174.7 million. On the other hand, next quarter's revenue guidance of $160 million was less impressive, coming in 10.4% below analysts' estimates. It made a GAAP profit of $0.76 per share, down from its profit of $3.67 per share in the same quarter last year.

Medifast Announces First Quarter 2024 Financial Results

2024-04-29
BALTIMORE, April 29, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2024.

Medifast, Inc. (MED) Q1 2024 Earnings Call Transcript

2024-04-29
Medifast, Inc. (NYSE:NYSE:MED) Q1 2024 Earnings Call Transcript April 29, 2024 4:30 PM ETCompany ParticipantsSteven Zenker - VP, IRDan Chard - Chairman...

Medifast: Q1 Earnings Snapshot

2024-04-29
BALTIMORE — BALTIMORE — Medifast Inc. on Monday reported earnings of $8.3 million in its first quarter. The Baltimore-based company said it had profit of 76 cents per share. Earnings,...

Medifast : MED Q1 2024 Earnings Supplement

2024-04-29
Medifast® Q1 2024 Earnings Supplement 22 This presentation contains forward-looking statements within the...

Medifast, Inc. 2024 Q1 - Results - Earnings Call Presentation

2024-04-29
The following slide deck was published by Medifast, Inc.

Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday

2024-04-29
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Market Today: Paramount Global Surges on Strong Q1 Performance Amid Mixed Corporate Earnings

2024-04-29
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Medifast sees Q2 EPS 5c-40c, two estimates 67c

2024-04-29
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.